Personal Utility and Early Intervention in Alzheimer’s Disease

Abstract

Neurosciences 69 (8):462–71. doi:10.1111/pcn.12289. Hegde, S., and R. Ellajosyula. 2016. Capacity issues and decision-making in dementia. Annals of Indian Academy of Neurology 19 (Suppl 1):S34–S39. doi:10.4103/09722327.192890. Jin, J. 2021. A case study of opinions on medical agency in Alzheimer’s disease and Alzheimer’s disease related dementias (AD/ADRD). Undergraduate honors thesis, Emory College of Arts and Sciences. https://etd.library. emory.edu/concern/etds/0g354g62j?locale=en Leo, R. J. 1999. Competency and the capacity to make treatment decisions: A primer for primary care physicians. Primary Care Companion to the Journal of Clinical Psychiatry 1 (5):131–41. doi:10.4088/pcc.v01n0501. Marmot, M. 2003. Self esteem and health. BMJ (Clinical Research ed.) 327 (7415):574–5. doi:10.1136/bmj.327.7415. 574. McKeown, A., G. S. Malhi, and I. Singh. 2021. Ethics of early intervention in Alzheimer’s disease. AJOB Neuroscience 12 (4): 212–223. doi:10.1080/21507740.2021.1896595. Moya-Alvarado, G., N. Gershoni-Emek, E. Perlson, and F. Bronfman. 2016. Neurodegeneration and Alzheimer’s disease (AD). What can proteomics tell us about the Alzheimer’s brain? Molecular & Cellular Proteomics 15 (2):409–25. doi:10.1074/mcp.R115.053330. Oruche, U. 2009. Research With Cognitively Impaired Participants. Journal of Nursing Law 13 (3):89–94. doi:10. 1891/1073-7472.13.3.89. Reiman, E. M., Y. T. Quiroz, A. S. Fleisher, K. Chen, C. Velez-Pardo, M. Jimenez-Del-Rio, A. M. Fagan, A. R. Shah, S. Alvarez, A. Arbelaez, et al. 2012. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer’s disease in the presenilin 1 E280A kindred: a case-control study. The Lancet Neurology 11 (12):1048–56. doi:10.1016/S14744422(12)70228-4. Traykov, L., A. Rigaud, P. Cesaro, and F. Boller. 2007. Neuropsychological impairment in the early Alzheimer’s disease. L’enc ephale 33 (3):310–6. doi:10.1016/S00137006(07)92044-8.